Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10315508" target="_blank" >RIV/00216208:11110/15:10315508 - isvavai.cz</a>

Alternative codes found

RIV/00064165:_____/15:10315508

Result on the web

<a href="http://dx.doi.org/10.1517/14740338.2015.1039980" target="_blank" >http://dx.doi.org/10.1517/14740338.2015.1039980</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1517/14740338.2015.1039980" target="_blank" >10.1517/14740338.2015.1039980</a>

Result language

angličtina

Original language name

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel

Original language description

Statins are one of the most commonly prescribed drugs in clinical practice. They are usually well tolerated and effectively prevent cardiovascular events. Most adverse effects associated with statin therapy are muscle-related. The recent statement of theEuropean Atherosclerosis Society (EAS) has focused on statin-associated muscle symptoms (SAMS), and avoided the use of the term 'statin intolerance'. Although muscle syndromes are the most common adverse effects observed after statin therapy, excludingother side effects might underestimate the number of patients with statin intolerance, which might be observed in 10 - 15% of patients. In clinical practice, statin intolerance limits effective treatment of patients at risk of, or with, cardiovascular disease. Knowledge of the most common adverse effects of statin therapy that might cause statin intolerance and the clear definition of this phenomenon is crucial to effectively treat patients with lipid disorders. Therefore, the aim of thi

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FR - Pharmacology and apothecary chemistry

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Expert Opinion on Drug Safety

ISSN

1474-0338

e-ISSN

—

Volume of the periodical

14

Issue of the periodical within the volume

6

Country of publishing house

GB - UNITED KINGDOM

Number of pages

21

Pages from-to

935-955

UT code for WoS article

000354541400012

EID of the result in the Scopus database

2-s2.0-84929578095